IN2014KN02752A - - Google Patents
Info
- Publication number
- IN2014KN02752A IN2014KN02752A IN2752KON2014A IN2014KN02752A IN 2014KN02752 A IN2014KN02752 A IN 2014KN02752A IN 2752KON2014 A IN2752KON2014 A IN 2752KON2014A IN 2014KN02752 A IN2014KN02752 A IN 2014KN02752A
- Authority
- IN
- India
- Prior art keywords
- cys11
- xaa14
- xaa15
- xaa13
- xaa8
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/060766 WO2013182240A1 (en) | 2012-06-06 | 2012-06-06 | Beta-hairpin peptidomimetics |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014KN02752A true IN2014KN02752A (ko) | 2015-05-08 |
Family
ID=46208596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2752KON2014 IN2014KN02752A (ko) | 2012-06-06 | 2012-06-06 |
Country Status (13)
Country | Link |
---|---|
US (2) | US9617308B2 (ko) |
EP (1) | EP2859012B1 (ko) |
JP (1) | JP6047231B2 (ko) |
CN (1) | CN104603145B (ko) |
AU (1) | AU2012381808B2 (ko) |
CA (1) | CA2875733C (ko) |
ES (1) | ES2647076T3 (ko) |
HK (1) | HK1207867A1 (ko) |
IL (1) | IL235946B (ko) |
IN (1) | IN2014KN02752A (ko) |
MX (1) | MX355396B (ko) |
SG (1) | SG11201407837WA (ko) |
WO (1) | WO2013182240A1 (ko) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2349879T3 (es) | 2007-02-28 | 2011-01-12 | Polyphor Ltd. | Peptidomiméticos fijados sobre patrón. |
JP6047231B2 (ja) * | 2012-06-06 | 2016-12-21 | ポリフォー・アクチェンゲゼルシャフトPolyphor Ag | β−ヘアピンペプチド模倣薬 |
US9308236B2 (en) | 2013-03-15 | 2016-04-12 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions |
CA2960778C (en) | 2014-09-11 | 2023-03-07 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions |
US9732119B2 (en) | 2014-10-10 | 2017-08-15 | Bristol-Myers Squibb Company | Immunomodulators |
US9856292B2 (en) | 2014-11-14 | 2018-01-02 | Bristol-Myers Squibb Company | Immunomodulators |
US9861680B2 (en) | 2014-12-18 | 2018-01-09 | Bristol-Myers Squibb Company | Immunomodulators |
US9944678B2 (en) | 2014-12-19 | 2018-04-17 | Bristol-Myers Squibb Company | Immunomodulators |
US20160222060A1 (en) | 2015-02-04 | 2016-08-04 | Bristol-Myers Squibb Company | Immunomodulators |
US9809625B2 (en) | 2015-03-18 | 2017-11-07 | Bristol-Myers Squibb Company | Immunomodulators |
US10143746B2 (en) | 2016-03-04 | 2018-12-04 | Bristol-Myers Squibb Company | Immunomodulators |
US10358463B2 (en) | 2016-04-05 | 2019-07-23 | Bristol-Myers Squibb Company | Immunomodulators |
MX2018014028A (es) | 2016-05-19 | 2019-04-04 | Squibb Bristol Myers Co | Inmunomoduladores de produccion de imagenes de tomografia por emision de positrones (pet). |
JP7100639B2 (ja) * | 2016-09-06 | 2022-07-13 | メインライン バイオサエンシズ | Cxcr4アンタゴニストおよび使用方法 |
KR102526034B1 (ko) | 2016-11-07 | 2023-04-25 | 브리스톨-마이어스 스큅 컴퍼니 | 면역조정제 |
US11066445B2 (en) | 2017-06-23 | 2021-07-20 | Bristol-Myers Squibb Company | Immunomodulators acting as antagonists of PD-1 |
CN111183146A (zh) * | 2017-09-05 | 2020-05-19 | 主线生物科学公司 | 高亲和力选择性结合cxcr4的缀合物及其使用方法 |
US11123437B2 (en) | 2017-09-05 | 2021-09-21 | Mainline Biosciences, Inc. | Selective CXCR4 binding peptide conjugate and methods for making and using the same |
KR20200058506A (ko) | 2017-10-03 | 2020-05-27 | 브리스톨-마이어스 스큅 컴퍼니 | 면역조정제 |
EP4097120A4 (en) * | 2020-01-26 | 2024-05-01 | Mainline Biosciences (Shanghai) Co., Ltd. | ISOTOPE-LABELED CXCR4 SELECTIVELY BINDING PEPTIDE CONJUGATE AND METHODS OF MAKING AND USE THEREOF |
MX2023005829A (es) | 2020-11-19 | 2023-08-21 | Spexis Ag | Combinaciones farmaceuticas para tratar el cancer. |
WO2022184320A2 (en) | 2021-03-03 | 2022-09-09 | Spexis Ag | Medical use of cyclic peptides |
WO2023285681A1 (en) | 2021-07-16 | 2023-01-19 | Spexis Ag | Pharmaceutical combinations for treating cancer |
WO2023285677A1 (en) | 2021-07-16 | 2023-01-19 | Spexis Ag | Pharmaceutical combinations for treating cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212288A (en) * | 1990-02-20 | 1993-05-18 | Syntex (U.S.A.) Inc. | Temporary minimal protection synthesis of serine-containing polypeptides |
AU2003232253A1 (en) * | 2003-05-02 | 2004-11-23 | Polyphor Ag | Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
JP5308829B2 (ja) * | 2006-02-27 | 2013-10-09 | テクニッシュ ユニべルシタット ミュンヘン | 癌の画像化および処置 |
ES2349879T3 (es) * | 2007-02-28 | 2011-01-12 | Polyphor Ltd. | Peptidomiméticos fijados sobre patrón. |
EP2427476B1 (en) | 2009-05-07 | 2018-08-08 | Polyphor Ag | Beta-hairpin peptidomimetics having cxcr4 antagonizing activity |
WO2011066869A1 (en) | 2009-12-04 | 2011-06-09 | Polyphor Ag | Beta-hairpin peptidomimetics |
WO2012168336A1 (en) * | 2011-06-07 | 2012-12-13 | Polyphor Ag | Beta - hairpin peptidomimetics as cxc4 antagonists |
JP6047231B2 (ja) * | 2012-06-06 | 2016-12-21 | ポリフォー・アクチェンゲゼルシャフトPolyphor Ag | β−ヘアピンペプチド模倣薬 |
-
2012
- 2012-06-06 JP JP2015515399A patent/JP6047231B2/ja not_active Expired - Fee Related
- 2012-06-06 AU AU2012381808A patent/AU2012381808B2/en active Active
- 2012-06-06 CN CN201280074311.1A patent/CN104603145B/zh active Active
- 2012-06-06 EP EP12725830.9A patent/EP2859012B1/en active Active
- 2012-06-06 ES ES12725830.9T patent/ES2647076T3/es active Active
- 2012-06-06 MX MX2014014840A patent/MX355396B/es active IP Right Grant
- 2012-06-06 SG SG11201407837WA patent/SG11201407837WA/en unknown
- 2012-06-06 IN IN2752KON2014 patent/IN2014KN02752A/en unknown
- 2012-06-06 CA CA2875733A patent/CA2875733C/en active Active
- 2012-06-06 US US14/406,108 patent/US9617308B2/en active Active
- 2012-06-06 WO PCT/EP2012/060766 patent/WO2013182240A1/en active Application Filing
-
2014
- 2014-11-27 IL IL235946A patent/IL235946B/en active IP Right Grant
-
2015
- 2015-08-31 HK HK15108479.6A patent/HK1207867A1/xx unknown
-
2017
- 2017-02-27 US US15/444,045 patent/US10363284B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9617308B2 (en) | 2017-04-11 |
AU2012381808B2 (en) | 2017-04-27 |
WO2013182240A1 (en) | 2013-12-12 |
IL235946B (en) | 2019-06-30 |
JP2015521204A (ja) | 2015-07-27 |
US20150218219A1 (en) | 2015-08-06 |
US10363284B2 (en) | 2019-07-30 |
EP2859012A1 (en) | 2015-04-15 |
AU2012381808A1 (en) | 2015-01-22 |
IL235946A0 (en) | 2015-01-29 |
HK1207867A1 (en) | 2016-02-12 |
CA2875733C (en) | 2019-09-10 |
CN104603145B (zh) | 2018-05-18 |
MX355396B (es) | 2018-04-18 |
US20170165319A1 (en) | 2017-06-15 |
CA2875733A1 (en) | 2013-12-12 |
JP6047231B2 (ja) | 2016-12-21 |
CN104603145A (zh) | 2015-05-06 |
SG11201407837WA (en) | 2014-12-30 |
NZ702470A (en) | 2016-12-23 |
EP2859012B1 (en) | 2017-08-09 |
MX2014014840A (es) | 2015-02-12 |
ES2647076T3 (es) | 2017-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014KN02752A (ko) | ||
MX343205B (es) | Peptidomiméticos de horquilla beta como antagonistas de cxc4. | |
MX2009008843A (es) | Peptidomimeticos fijados a un patron. | |
WO2017163132A3 (en) | Use of umbilical cord blood derived exosomes for tissue repair | |
NZ602471A (en) | Antagonists of activin-actriia and uses for increasing red blood cell levels | |
WO2013079701A3 (en) | Expression of mirnas in placental tissue | |
ES2397889A1 (es) | PÉPTIDOS MODULADORES DE PGC-1Alfa. | |
MX2017007814A (es) | Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico. | |
PH12014502041A1 (en) | Heterocyclyl compounds as mek inhibitors | |
MX2017012393A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
EA201890236A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
JP2012041342A5 (ko) | ||
MX363050B (es) | Composición inmunogénica para modulación del sistema inmune y su uso, metodo de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune. | |
RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
JP2017532343A5 (ko) | ||
GR1007832B (el) | Αδρανοποιητες της ακτιβινης και χρηση τους για την θεραπεια ασθενειων που σχετιζονται με παρεκκλινουσα ενεργοποιηση της "αμυντικης αποκρισης του ξενιστη" | |
GB2546224A (en) | Method and composition for producing enhanced anti-inflammatory/ anti-catabolic and regenerative agents from autologous physiological fluid | |
BR112012028437A2 (pt) | solução oftálmica, e, método para tratar glaucoma ou hipertensão ocular | |
GEP201706716B (en) | Optimised subcutaneous therapeutic agents | |
MX2015007402A (es) | Fusion de hormona de crecimiento humano y albumina, formulacion y usos de los mismos. | |
EA201691328A1 (ru) | Бета-шпилечные пептидомиметики в качестве селективных ингибиторов эластазы | |
RU2014145351A (ru) | КОМБИНАЦИЯ АНАЛОГОВ СОМАТОСТАТИНА С ИНГИБИТОРАМИ 11β-ГИДРОКСИЛАЗЫ | |
EA201591095A1 (ru) | Белок slurp-1 для применения в лечении глазных болезней | |
NZ702666A (en) | A method of weight reduction | |
EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода |